FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver diseaseThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into.[Collection]

The FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into.https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html